Proteína C reactiva y grosor íntima-media carotídeo en pacientes con ictus isquémico aterotrombótico

CRP is a marker of increased IMT in patients with atherothrombotic ischemic stroke. A cutoff point of 1.5 mg/dl for CRP provided a greater IMT and a worse outcome in functional disability as cardiovascular risk. Therefore, this group requires a more intensive treatment in secondary prevention.